Clinical Trials Logo

Filter by:
NCT ID: NCT05081843 Completed - Adolescent Behavior Clinical Trials

Pittsburgh and Rural Area High School Tobacco Prevention

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This research project will explore the feasibility and acceptability of a web-based media literacy tobacco prevention program. The project will be conducted with 9th graders in two schools in the Pittsburgh area.

NCT ID: NCT05081817 Completed - Type 2 Diabetes Clinical Trials

Accuracy Comparison of Two CGMs in Hospitalized Patients

Start date: August 1, 2019
Phase:
Study type: Observational

The purpose of the study is to determine the accuracy of two different continuous blood sugar monitoring systems in hospitalized patients by comparing them standard laboratory blood sugar testing in the hospital.

NCT ID: NCT05081427 Completed - Clinical trials for Nonalcoholic Fatty Liver

Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2

Start date: November 15, 2021
Phase:
Study type: Observational

This study is a prospective, observational, single-center, short-term cross-sectional study to assess the repeatability and reproducibility of a set of specified MRI quantitative biomarkers.

NCT ID: NCT05081167 Completed - Clinical trials for Major Depressive Disorder

A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)

Reliance III
Start date: June 2, 2021
Phase: Phase 3
Study type: Interventional

This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of REL-1017 once daily (QD) as a monotherapy for Major Depressive Disorder.

NCT ID: NCT05081154 Completed - Smoking Clinical Trials

CSD201002: Study to Assess Nicotine Uptake From P10 Nicotine Pouches

Start date: October 20, 2021
Phase: N/A
Study type: Interventional

This study is a single-center, open-label, randomized, 7-way crossover study designed to evaluate plasma nicotine pharmacokinetics (PK) parameters following use of the study investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers.

NCT ID: NCT05081063 Completed - Clinical trials for Traumatic Brain Injury

Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients

Start date: March 5, 2022
Phase: Phase 3
Study type: Interventional

Adult male patients brought to the emergency department as Level A trauma activations who are receiving emergency blood transfusion. Objectives 1. Evaluate PRBC equivalents transfused in each group in the first 24 hours (Primary outcome) 2. Evaluate total transfusion in each group in the first 24 hours (Secondary Outcome) including breakdown by FFP equivalents, platelet units, and cryoprecipitate 3. Evaluate 6 hour, 24 hour, and hospital mortality (Secondary Outcome) 4. Evaluate ICU outcomes in each group

NCT ID: NCT05081011 Completed - Clinical trials for Medication Adherence

Managing Insulin With a Voice AI

MIVA
Start date: March 24, 2021
Phase: N/A
Study type: Interventional

This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.

NCT ID: NCT05080959 Completed - Clinical trials for Inguinal Herniorrhaphy

A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy

Start date: July 28, 2021
Phase: Phase 2
Study type: Interventional

This is a Phase 2b, randomized, double blind, placebo and active controlled study with an Ascending Dose Stage and an optional Dose Expansion Stage in subjects undergoing open inguinal herniorrhaphy with mesh.

NCT ID: NCT05080777 Completed - Alzheimer Disease Clinical Trials

Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems

Start date: September 28, 2021
Phase: N/A
Study type: Interventional

This cluster randomized pragmatic clinical trial will test the effectiveness and feasibility of embedding the Tele-Savvy intervention, a psychoeducational program for family and other informal caregivers of older adults living in the community with Alzheimer's disease and related dementia (ADRD), in two health care systems/clinical sites: UConn Health in Farmington, Connecticut, and Emory Healthcare in Atlanta, Georgia.

NCT ID: NCT05080725 Completed - Dysphagia Clinical Trials

Measuring Pharyngeal Muscle Improvements Following Behavioral Swallowing Exercises

Start date: May 24, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about how exercise and protein supply affect swallow muscles. Twenty healthy older adults will be recruited from local community centers, physician offices, and retirement communities via flyers. Participants will complete 16 sessions of standard of care swallowing exercises 2 times per week for 8 weeks. All sessions will be conducted via Zoom. During each session, a series of swallow exercises will be performed following a demonstration from a trained speech-language pathologist. Participants will be referred to NYU Langone Health or White Plains Hospital, for a videofluoroscopic swallowing study, acoustic pharyngometry and measures of hand grip strength before and after the treatment protocol. Patients will be able to select their preferred site for swallow study completion. Results will inform the relationship between swallow exercises and pharyngeal muscles. All devices and exercises are established as safe and effective and are FDA approved.